Liver disease and heart failure: Back and forth

M Correale, N Tarantino, R Petrucci, L Tricarico… - European journal of …, 2018 - Elsevier
In their clinical practice, physicians can face heart diseases (chronic or acute heart failure)
affecting the liver and liver diseases affecting the heart. Systemic diseases can also affect …

Atrial fibrillation and cancer; understanding the mysterious relationship through a systematic review

N Lateef, V Kapoor, MJ Ahsan, A Latif… - Journal of community …, 2020 - Taylor & Francis
ABSTRACT Background Atrial Fibrillation (AFib) is the most common cardiac arrhythmia,
occurring in≈ 1% of the general population. An increased risk of malignancy among …

Metabolic activation and cytotoxicity of propafenone mediated by CYP2D6

J Li, J Shi, C Jia, W Li, Y Peng… - Chemical Research in …, 2022 - ACS Publications
Propafenone (PPF) is a class IC antidysrhythmic drug, which is commonly used for the
treatment of atrial fibrillation and other supraventricular arrhythmias. It is also a β …

[HTML][HTML] Gastrointestinal side effects of antiarrhythmic medications: a review of current literature

W Amjad, W Qureshi, A Farooq, U Sohail, S Khatoon… - Cureus, 2017 - ncbi.nlm.nih.gov
Antiarrhythmic drugs are commonly prescribed cardiac drugs. Due to their receptor mimicry
with several of the gastrointestinal tract receptors, they can frequently lead to gastrointestinal …

Antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts

YP Lim, CL Lin, YN Lin, WC Ma, WC Chen, DZ Hung… - PLoS …, 2015 - journals.plos.org
Background The objective of this study was to determine the association between the use of
antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts …

Propafenone-Induced Cholestatic Liver Injury: When Diagnosis Does Not Skip a Beat

AI Ferreira, V Macedo Silva, C Arieira… - GE-Portuguese Journal …, 2024 - karger.com
Introduction: Propafenone is a widely used class Ic antiarrhythmic drug that is mainly
metabolised by the liver. Hepatotoxicity associated with propafenone is rare, with only a few …

PROPAFENONE-INDUCED LIVER INJURY IN AN ELDERLY PATIENT WITH PAROXYSMAL ATRIAL FIBRILLATION-A NEW CASE REPORT AND LITERATURE …

K Giedzicz, M Dytkowski, J Rentflejsz… - Acta Poloniae …, 2023 - search.ebscohost.com
Antiarrhythmic drugs are used more and more often, which is related to the aging of the
population and the growing number of arrhythmias, especially atrial fibrillation (AF). One of …

[图书][B] Erişkinlerde ACİL BAKIM

FE Aslan, N Olgun - 2021 - books.google.com
Page 1 ACİLBAKIM Editörler Prof. Dr. Fatma ETİ ASLAN Prof. Dr. Nermin OLGUN
akademisyenyayinevi akademisyen com AKADEMİSYEN KİTABEVİ Güncellenmiş …

Positive Inotropic Drugs and Drugs Used in Dysrhythmias

KA Mitręga, M Stankiewicz, TF Krzeminski - Side Effects of Drugs Annual, 2014 - Elsevier
Abstract The Side Effects of Drugs Annuals form a series of volumes in which the adverse
effects of drugs and adverse reactions to them are surveyed. The series supplements the …

[PDF][PDF] RENAN DONOMAE IWAMOTO

CDABE FORMULAÇÃO-TESTE… - core.ac.uk
Propafenone hydrochloride is a 1C class of antiarrhythmic drug, which exerts a membrane
stabilizing effect on the myocardial cell. It has sodium channel blocking properties in the …